301 related articles for article (PubMed ID: 20956180)
1. Prevention of exacerbations of COPD with pharmacotherapy.
Miravitlles M
Eur Respir Rev; 2010 Jun; 19(116):119-26. PubMed ID: 20956180
[TBL] [Abstract][Full Text] [Related]
2. Prediction and prevention of exacerbations and mortality in patients with COPD.
Kostikas K; Clemens A; Patalano F
Expert Rev Respir Med; 2016 Jul; 10(7):739-53. PubMed ID: 27135786
[TBL] [Abstract][Full Text] [Related]
3. [Acute exacerbation in COPD and asthma].
Yıldırım N; Demir T; Gemicioğlu B; Kıyan E; Oğuzülgen K; Polatlı M; Saryal S; Sayıner A; Yorgancıoğlu A; Bavbek S; Çelik GE; Günen H; Mungan D; Şen E; Türktaş H; Yıldız F
Tuberk Toraks; 2015 Jun; 63(2):111-31. PubMed ID: 26167969
[TBL] [Abstract][Full Text] [Related]
4. Interventions to reduce the frequency of exacerbations of chronic obstructive pulmonary disease.
Black PN; McDonald CF
Postgrad Med J; 2009 Mar; 85(1001):141-7. PubMed ID: 19351641
[TBL] [Abstract][Full Text] [Related]
5. Dual combination therapy versus long-acting bronchodilators alone for chronic obstructive pulmonary disease (COPD): a systematic review and network meta-analysis.
Oba Y; Keeney E; Ghatehorde N; Dias S
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012620. PubMed ID: 30521694
[TBL] [Abstract][Full Text] [Related]
6. Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease.
Poole P; Sathananthan K; Fortescue R
Cochrane Database Syst Rev; 2019 May; 5(5):CD001287. PubMed ID: 31107966
[TBL] [Abstract][Full Text] [Related]
7. Impact of Mucolytic Agents on COPD Exacerbations: A Pair-wise and Network Meta-analysis.
Cazzola M; Rogliani P; Calzetta L; Hanania NA; Matera MG
COPD; 2017 Oct; 14(5):552-563. PubMed ID: 28753070
[TBL] [Abstract][Full Text] [Related]
8. Exacerbations of chronic obstructive pulmonary disease.
Wedzicha JA; Donaldson GC
Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
[TBL] [Abstract][Full Text] [Related]
9. Chronic obstructive pulmonary disease: Useful medications for patients with recurrent symptoms.
Prescrire Int; 2016 Nov; 25(176):272-277. PubMed ID: 30715829
[TBL] [Abstract][Full Text] [Related]
10. Medication Regimens for Managing COPD Exacerbations.
Putcha N; Wise RA
Respir Care; 2018 Jun; 63(6):773-782. PubMed ID: 29794210
[TBL] [Abstract][Full Text] [Related]
11. Treatment of chronic obstructive pulmonary disease and its exacerbations in general practice. EOLO Group. Estudio Observacional de la Limitación Obstructiva al Flujo aEreo.
Miravitlles M; Mayordomo C; Artés M; Sánchez-Agudo L; Nicolau F; Segú JL
Respir Med; 1999 Mar; 93(3):173-9. PubMed ID: 10464874
[TBL] [Abstract][Full Text] [Related]
12. Role of mucolytics in the management of COPD.
Poole PJ
Int J Chron Obstruct Pulmon Dis; 2006; 1(2):123-8. PubMed ID: 18046889
[TBL] [Abstract][Full Text] [Related]
13. The evidence for the use of oral mucolytic agents in chronic obstructive pulmonary disease (COPD).
Davies L; Calverley PM
Br Med Bull; 2010; 93():217-27. PubMed ID: 20031934
[TBL] [Abstract][Full Text] [Related]
14. [Prevention of acute exacerbation of chronic obstructive pulmonary disease].
Chen S; Chen P
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 Aug; 39(8):861-7. PubMed ID: 25202957
[TBL] [Abstract][Full Text] [Related]
15. Combined aclidinium bromide and long-acting beta2-agonist for chronic obstructive pulmonary disease (COPD).
Ni H; Moe S; Soe Z; Myint KT; Viswanathan KN
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011594. PubMed ID: 30536566
[TBL] [Abstract][Full Text] [Related]
16. Exacerbations of COPD.
Viniol C; Vogelmeier CF
Eur Respir Rev; 2018 Mar; 27(147):. PubMed ID: 29540496
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacological management of stable COPD].
Rauscher H
Wien Med Wochenschr; 2005 Mar; 155(5-6):95-100. PubMed ID: 15884489
[TBL] [Abstract][Full Text] [Related]
18. Inhaled drugs to reduce exacerbations in patients with chronic obstructive pulmonary disease: a network meta-analysis.
Puhan MA; Bachmann LM; Kleijnen J; Ter Riet G; Kessels AG
BMC Med; 2009 Jan; 7():2. PubMed ID: 19144173
[TBL] [Abstract][Full Text] [Related]
19. Impact and prevention of severe exacerbations of COPD: a review of the evidence.
Halpin DM; Miravitlles M; Metzdorf N; Celli B
Int J Chron Obstruct Pulmon Dis; 2017; 12():2891-2908. PubMed ID: 29062228
[TBL] [Abstract][Full Text] [Related]
20. Guideline for the management of chronic obstructive pulmonary disease--2011 update.
Abdool-Gaffar MS; Ambaram A; Ainslie GM; Bolliger CT; Feldman C; Geffen L; Irusen EM; Joubert J; Lalloo UG; Mabaso TT; Nyamande K; O'Brien J; Otto W; Raine R; Richards G; Smith C; Stickells D; Venter A; Visser S; Wong M;
S Afr Med J; 2011 Jan; 101(1 Pt 2):63-73. PubMed ID: 21526617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
